Mr. McAllister recently joined the Amendia team beginning in January 2017. Prior to joining Amendia, Mr. McAllister served as Chief Financial Officer of InVivo Therapeutics from December 2013 to December 2016 where he was responsible for all finance and IT related activities and he led the company’s uplisting to NASDAQ. Prior to joining InVivo, he served as Vice President of Finance and Administration for the Spine and Bone Healing Technologies division of Biomet, Inc. from September 2007 to March 2013. While at Biomet, he managed all accounting, finance, IT, facilities and insurance operations activities in addition to leading the company's strategic planning initiatives.
Prior to Biomet, Mr. McAllister worked for DePuy, Inc., a Johnson & Johnson Company, from 1999 to 2007, in various capacities of increasing responsibility including Controller—Marketing Finance, Director of Finance—Worldwide Spine, and Director of Finance—Worldwide Operations. Prior to DePuy, Mr. McAllister held various financial roles with Pfizer's medical device business from 1984 to 1999. Mr. McAllister holds a B.S. in Accounting from Fairleigh Dickinson University.